4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-16-053380
Options or other derivatives
- Senior VP - Drug Discovery acquired 129,427 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-23 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +129,427 | $3.22 | 2026-05-23 | 129,427 | 129,427 | D |
Loading xslF345X03/form4.xml…